Paul A. Wender
36Patents
12h-index
64Co-inventors
84Inventor score
Filing activity: May 21, 1998 → Jan 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6306993A | Method and composition for enhancing transport across biological membranes | Chemistry; Metallurgy | 212 | Expired |
| US6495663B1 | Method and composition for enhancing transport across biological membranes | Chemistry; Metallurgy | 171 | Expired |
| US6669951B2 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Human Necessities | 100 | Expired |
| US6593292B1 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Chemistry; Metallurgy | 92 | Expired |
| US7169814B2 | Guanidinium transport reagents and conjugates | Human Necessities | 48 | Expired |
| US8246995B2 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | Performing Operations; Transporting | 47 | Active |
| US7585834B2 | Transporters comprising spaced arginine moieties | Human Necessities | 44 | Expired |
| US6730293B1 | Compositions and methods for treating inflammatory diseases of the skin | Chemistry; Metallurgy | 40 | Expired |
| US6759387B2 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Chemistry; Metallurgy | 39 | Expired |
| US7229961B2 | Compositions and methods for enhancing drug delivery across and into ocular tissues | Human Necessities | 28 | Expired |
| US6624189B2 | Byrostatin analogues, synthetic methods and uses | Chemistry; Metallurgy | 17 | Expired |
| US8623833B2 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Human Necessities | 15 | Active |
| US7256286B2 | Bryostatin analogues, synthetic methods and uses | Chemistry; Metallurgy | 10 | Expired |
| US7232842B2 | Kinase inhibitors and associated pharmaceutical compositions and methods of use | Chemistry; Metallurgy | 7 | Expired |
| US7939621B2 | Oligocarbonate molecular transporters | Emerging Cross-Sectional Technologies | 6 | Active |
| US8278264B2 | Compositions and methods for enhancing drug delivery across and into ocular tissues | Human Necessities | 5 | Active |
| US8816122B2 | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use | Chemistry; Metallurgy | 5 | Active |
| US8497385B2 | Bryostatin analogues, synthetic methods and uses | Chemistry; Metallurgy | 5 | Active |
| US7151116B2 | Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells | Chemistry; Metallurgy | 5 | Expired |
| US8729010B2 | Compositions and methods for enhancing drug delivery across and into ocular tissues | Human Necessities | 4 | Active |
| US8067632B2 | Process to produce prostratin and structural or functional analogs thereof | Chemistry; Metallurgy | 3 | Active |
| US7067698B2 | Bi-directional synthesis of oligoguanidine transport agents | Chemistry; Metallurgy | 3 | Expired |
| US8735609B2 | Bryostatin analogues, synthetic methods and uses | Chemistry; Metallurgy | 2 | Active |
| US8536378B2 | Prostratin and structural or functional analogs thereof | Chemistry; Metallurgy | 2 | Active |
| US10947221B2 | Bryostatin compounds and methods of preparing the same | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.